🇺🇸 FDA
Pipeline program

TTX-MC138

TTX-MC138-002

Phase 2 small_molecule active

Quick answer

TTX-MC138 for Advanced Solid Tumor is a Phase 2 program (small_molecule) at Transcode Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Transcode Therapeutics
Indication
Advanced Solid Tumor
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials